Tempest Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tempest Therapeutics, Inc. has filed 1,016 SEC EDGAR filings since 09 Apr 2012

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
S-8 File 333-286186

S-8

Filing date
27 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87213

SCHEDULE 13D/A filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-280918

424B5

Filing date
06 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-280918

EFFECT filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-280918

S-3/A

Filing date
24 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35890

DEF 14A

Filing date
12 Nov 2024
Reporting date
03 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .